CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT (UNAUDITED) - USD ($) $ in Thousands	Total	Revision of Prior Period, Accounting Standards Update, Adjustment	Securities Purchase Agreement	Common Stock	Common Stock Securities Purchase Agreement	Additional Paid - In Capital	Additional Paid - In Capital Securities Purchase Agreement	Subscription Receivable	Cumulative Translation Adjustment	Accumulated Deficit	Accumulated Deficit Revision of Prior Period, Accounting Standards Update, Adjustment
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2022				4,625,278
Stockholders' equity, beginning balance at Dec. 31, 2022	$ (47,047)			$ 0		$ 293,774		$ 0	$ (357)	$ (340,464)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	481					481
Issuance of shares in connection with Securities Purchase Agreement and Issuance of shares, net of issuance costs (in shares)				1,211,926
Issuance of shares in connection with Securities Purchase Agreement and Issuance of shares, net of issuance costs	8,096			$ 1		8,095
Restricted shares award issuance, net of withholdings (in shares)				9,275
Proceeds from stock options exercised (in shares)				133,333
Proceeds from stock options exercised	1,000					1,000
Foreign currency translation adjustment	17								17
Net loss	(8,171)									(8,171)
Stockholders' equity ending balance (in shares) at Mar. 31, 2023				5,979,812
Stockholders equity, ending balance at Mar. 31, 2023	(45,624)			$ 1		303,350		0	(340)	(348,635)
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2022				4,625,278
Stockholders' equity, beginning balance at Dec. 31, 2022	(47,047)			$ 0		293,774		0	(357)	(340,464)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Foreign currency translation adjustment	15
Net loss	(32,452)
Stockholders' equity ending balance (in shares) at Sep. 30, 2023				7,310,481
Stockholders equity, ending balance at Sep. 30, 2023	(65,227)			$ 1		308,030		0	(342)	(372,916)
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2022				4,625,278
Stockholders' equity, beginning balance at Dec. 31, 2022	(47,047)			$ 0		293,774		0	(357)	(340,464)
Stockholders' equity ending balance (in shares) at Dec. 31, 2023				9,131,252
Stockholders equity, ending balance at Dec. 31, 2023	$ (51,024)	$ 22		$ 1		319,992		(698)	(345)	(369,974)	$ 22
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2023-08 [Member]
Stockholders' equity, beginning balance (in shares) at Mar. 31, 2023				5,979,812
Stockholders' equity, beginning balance at Mar. 31, 2023	$ (45,624)			$ 1		303,350		0	(340)	(348,635)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	568					568
Issuance of shares in connection with Securities Purchase Agreement and Issuance of shares, net of issuance costs (in shares)				1,253,434
Issuance of shares in connection with Securities Purchase Agreement and Issuance of shares, net of issuance costs	3,320			$ 0		3,320
Restricted shares award issuance, net of withholdings (in shares)				3,368
Foreign currency translation adjustment	10								10
Net loss	(10,042)									(10,042)
Stockholders' equity ending balance (in shares) at Jun. 30, 2023				7,236,614
Stockholders equity, ending balance at Jun. 30, 2023	(51,768)			$ 1		307,238		0	(330)	(358,677)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	482					482
Issuance of shares in connection with Securities Purchase Agreement and Issuance of shares, net of issuance costs (in shares)				73,825
Issuance of shares in connection with Securities Purchase Agreement and Issuance of shares, net of issuance costs	310					310
Restricted shares award issuance, net of withholdings (in shares)				42
Foreign currency translation adjustment	(12)								(12)
Net loss	(14,239)									(14,239)
Stockholders' equity ending balance (in shares) at Sep. 30, 2023				7,310,481
Stockholders equity, ending balance at Sep. 30, 2023	(65,227)			$ 1		308,030		0	(342)	(372,916)
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2023				9,131,252
Stockholders' equity, beginning balance at Dec. 31, 2023	(51,024)	22		$ 1		319,992		(698)	(345)	(369,974)	22
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	1,070					1,070
Issuance of shares in connection with Securities Purchase Agreement and Issuance of shares, net of issuance costs (in shares)				45,269	450,300
Issuance of shares in connection with Securities Purchase Agreement and Issuance of shares, net of issuance costs	1,038		$ 1,133			340	$ 1,133	698
Restricted shares award issuance (in shares)				159,357
Issuance of warrants in connection with Securities Purchase Agreement	4,866					4,866
Foreign currency translation adjustment	(3)								(3)
Net loss	(3,944)									(3,944)
Stockholders' equity ending balance (in shares) at Mar. 31, 2024				9,786,178
Stockholders equity, ending balance at Mar. 31, 2024	(46,842)			$ 1		327,401		0	(348)	(373,896)
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2023				9,131,252
Stockholders' equity, beginning balance at Dec. 31, 2023	$ (51,024)	$ 22		$ 1		319,992		(698)	(345)	(369,974)	$ 22
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issuance upon exercise of prefunded warrant (in shares)	810,205
Foreign currency translation adjustment	$ (3)
Net loss	(15,879)
Stockholders' equity ending balance (in shares) at Sep. 30, 2024				10,671,337
Stockholders equity, ending balance at Sep. 30, 2024	(58,049)			$ 1		328,129		0	(348)	(385,831)
Stockholders' equity, beginning balance (in shares) at Mar. 31, 2024				9,786,178
Stockholders' equity, beginning balance at Mar. 31, 2024	(46,842)			$ 1		327,401		0	(348)	(373,896)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	311					311
Common stock issuance upon exercise of prefunded warrant (in shares)				810,205
Restricted shares award issuance (in shares)				27,604
Net loss	(5,568)									(5,568)
Stockholders' equity ending balance (in shares) at Jun. 30, 2024				10,623,987
Stockholders equity, ending balance at Jun. 30, 2024	(52,099)			$ 1		327,712		0	(348)	(379,464)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	417					417
Restricted shares award issuance (in shares)				47,350
Foreign currency translation adjustment	0
Net loss	(6,367)									(6,367)
Stockholders' equity ending balance (in shares) at Sep. 30, 2024				10,671,337
Stockholders equity, ending balance at Sep. 30, 2024	$ (58,049)			$ 1		$ 328,129		$ 0	$ (348)	$ (385,831)